Zacks Investment Research lowered shares of Hill-Rom Holdings Inc (NYSE:HRC) from a buy rating to a hold rating in a report released on Tuesday morning.
According to Zacks, “Hill-Rom exited fiscal 2017 on a strong note with fourth-quarter earnings and revenues beating the Zacks Consensus Estimate. The company saw a solid year-over-year increase in revenues on strong international growth. Hill-Rom is currently focused on gaining traction in the untapped international market on successful execution of the company’s strategy, courtesy its efficient international team and organizational realignment. The company is focusing on product innovation through research and development. A slew of product launches in the fourth quarter is encouraging. Moreover, an improvement in adjusted and operating margin buoys optimism. However, a decline in revenues at the Patient Support Systems segment is quite disappointing. Also, foreign exchange and a tough competitive landscape remain headwinds.Overall, Hill-Rom has underperformed the broader industry in the last six months.”
Several other research analysts also recently issued reports on the company. Barclays PLC upped their price objective on Hill-Rom Holdings from $86.00 to $90.00 and gave the stock an overweight rating in a report on Monday, November 6th. Stifel Nicolaus upped their price objective on Hill-Rom Holdings from $84.00 to $85.00 and gave the stock a buy rating in a report on Monday, November 6th. KeyCorp reaffirmed a buy rating and set a $89.00 price objective (up previously from $82.00) on shares of Hill-Rom Holdings in a report on Sunday, November 5th. Needham & Company LLC reduced their price objective on Hill-Rom Holdings from $93.00 to $90.00 and set a buy rating on the stock in a report on Monday, November 6th. Finally, ValuEngine downgraded Hill-Rom Holdings from a buy rating to a hold rating in a report on Saturday, November 4th. Four research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The company presently has an average rating of Buy and an average price target of $88.57.
Hill-Rom Holdings (HRC) traded down $1.79 during trading hours on Tuesday, reaching $76.18. The company’s stock had a trading volume of 621,200 shares, compared to its average volume of 511,700. Hill-Rom Holdings has a 12-month low of $52.58 and a 12-month high of $84.65. The company has a debt-to-equity ratio of 1.55, a quick ratio of 1.34 and a current ratio of 1.77. The firm has a market cap of $5,136.72, a P/E ratio of 20.20, a price-to-earnings-growth ratio of 1.66 and a beta of 1.19.
Hill-Rom Holdings (NYSE:HRC) last posted its quarterly earnings data on Friday, November 3rd. The medical technology company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.05. Hill-Rom Holdings had a return on equity of 20.27% and a net margin of 4.87%. The firm had revenue of $738.30 million for the quarter, compared to the consensus estimate of $731.10 million. During the same quarter in the prior year, the business earned $1.18 EPS. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. analysts forecast that Hill-Rom Holdings will post 4.26 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Hill-Rom Holdings Inc (HRC) Downgraded to Hold at Zacks Investment Research” was first reported by BBNS and is owned by of BBNS. If you are accessing this story on another site, it was illegally stolen and reposted in violation of United States & international copyright laws. The legal version of this story can be accessed at https://baseballnewssource.com/markets/hill-rom-holdings-inc-hrc-downgraded-to-hold-at-zacks-investment-research/1764728.html.
The business also recently declared a quarterly dividend, which will be paid on Friday, December 29th. Stockholders of record on Friday, December 15th will be paid a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.95%. The ex-dividend date is Thursday, December 14th. Hill-Rom Holdings’s dividend payout ratio (DPR) is currently 36.18%.
In other news, SVP Andreas G. Frank sold 6,870 shares of the stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $77.48, for a total value of $532,287.60. Following the transaction, the senior vice president now owns 16,701 shares of the company’s stock, valued at approximately $1,293,993.48. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Andreas G. Frank sold 3,940 shares of the stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $77.84, for a total value of $306,689.60. Following the completion of the transaction, the senior vice president now directly owns 16,701 shares in the company, valued at approximately $1,300,005.84. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company’s stock.
Several hedge funds have recently bought and sold shares of the company. Wells Fargo & Company MN lifted its stake in shares of Hill-Rom Holdings by 298.1% in the 3rd quarter. Wells Fargo & Company MN now owns 1,133,900 shares of the medical technology company’s stock valued at $83,908,000 after purchasing an additional 849,050 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in Hill-Rom Holdings by 10.0% during the 3rd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 9,611 shares of the medical technology company’s stock worth $711,000 after buying an additional 877 shares during the period. Virginia Retirement Systems ET AL raised its stake in Hill-Rom Holdings by 246.0% during the 3rd quarter. Virginia Retirement Systems ET AL now owns 17,300 shares of the medical technology company’s stock worth $1,280,000 after buying an additional 12,300 shares during the period. Legal & General Group Plc raised its stake in Hill-Rom Holdings by 16.4% during the 3rd quarter. Legal & General Group Plc now owns 62,049 shares of the medical technology company’s stock worth $4,592,000 after buying an additional 8,765 shares during the period. Finally, Great West Life Assurance Co. Can raised its stake in Hill-Rom Holdings by 5.8% during the 3rd quarter. Great West Life Assurance Co. Can now owns 39,533 shares of the medical technology company’s stock worth $2,894,000 after buying an additional 2,179 shares during the period. 81.92% of the stock is currently owned by institutional investors.
About Hill-Rom Holdings
Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with our FREE daily email newsletter.